MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- China: A human case of avian influenza A(H9N2) reported in Sichuan province 9 days ago
- China: A human case of avian influenza A(H5N6) reported in Chongqing Municipality (the case resided in Sichuan province) Aug, 23, 2023
- China: A human case of avian influenza A(H9N2) reported in Sichuan Province Aug, 17, 2023
- China: A human case of avian influenza A(H5N6) reported in Chongqing Municipality Aug, 17, 2023
- China: A H5N1 HPAIV outbreak in wild birds reported in Naqu city of Xizang Autonomous Region Jul, 28, 2023
[Go Top] [Close Window]